-+ 0.00%
-+ 0.00%
-+ 0.00%

BridgeBio Pharma Inc. releases Phase 3 FORTIFY BBP-418 interim analysis presentation for LGMD2I/R9

Reuters·03/11/2026 19:49:42

Please log in to view news